Discover how your treatment decision could affect
your patients with SHPT
/sites/g/files/brlbcj1106/files/2020-03/bg_1400-min.png
HOW STABLE ARE
YOUR PATIENTS
WITH SHPT?
SHPT: secondary hyperparathyroidism.
MED-HQ-NA-2000013
Date of preparation: May 2020
Vifor Fresenius Medical Care Renal Pharma Ltd